This company has been acquired
DICE Therapeutics Dividend
Dividend criteria checks 0/6
DICE Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.4% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$2.18 |
Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
We're Not Very Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Rate
May 14DICE Therapeutics positive phase 1 data for psoriasis candidate leads shares 71% higher
Oct 11Here's Why We're Not Too Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Situation
Sep 11DICE Therapeutics GAAP EPS of -$0.58
Aug 11DICE Therapeutics initiated at buy at Wainwright on platform for small molecule drugs
Jul 18Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if DICE's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if DICE's dividend payments have been increasing.
Dividend Yield vs Market
DICE Therapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (DICE) | n/a |
Market Bottom 25% (US) | 1.6% |
Market Top 25% (US) | 4.9% |
Industry Average (Pharmaceuticals) | 2.4% |
Analyst forecast in 3 Years (DICE) | 0% |
Notable Dividend: Unable to evaluate DICE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate DICE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as DICE has not reported any payouts.